Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
If your goals shift, timing matters. Learn how to adjust spending and savings so your budget stays aligned with new targets.
18,573 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Investors are watching Lilly stock: next stop as the company leverages obesity and diabetes drugs, while facing risin...
A fresh round of U.S. quantum funding sparked optimism in the stock market today, lifting IonQ and other quantum play...
Berkshire Hathaway's Bank of America stake remains a defining part of its portfolio, even as the company reshapes its...
NVIDIA stock struggled over the last week despite solid earnings. This guide breaks down the reasons behind the move ...
CoreWeave stock recently jumped on fresh analyst optimism and AI-fueled demand for data center capacity. This guide b...
A recent SEC 13F shows Midland Wealth Advisors initiating a stake in Bluerock Private Real Estate Fund. Learn why thi...
Looking for better income from corporate credit? This guide breaks down long corporate bond etfs like IGLB and VCLT, ...
Tariff rules matter to everyday prices and jobs. This article explains why failing renew USMCA would raise uncertaint...
Bitcoin's renewed drop pulled Strategy, BitMine, and Robinhood shares toward monthly lows. This article breaks down w...
After a short three-day drift, major averages regained their footing on Thursday. The Dow, S&P 500, and NASDAQ logged...
As markets swing and tax rules shift, households with a $450K+ 401K are weighing year-end charity moves. A Donor-Advi...